In the PREFER trial, researchers aimed to investigate and assess the safety of strategies for fertility preservation in ...

The BOOG 2013-08 trial evaluates whether SLNB can be safely omitted for patients with clinically T1-2N0 treated with ...

In this retrospective cohort study of a large population in Belgium, researchers aimed to examine endometrial cancer risk in patients with breast cancer who received tamoxifen.

Investigator sought to compare treatment strategies that omit chemotherapy and/or include ribociblib against standard treatment for safety and efficacy.

The HER2CLIMB-05 study assessed the efficacy and safety of adding tucatinib to maintenance therapy with trastuzumab/pertuzumab in patients with HER2+ metastatic breast cancer.